163 related articles for article (PubMed ID: 37574347)
1. Disulfidptosis: disulfide stress-induced cell death.
Liu X; Zhuang L; Gan B
Trends Cell Biol; 2024 Apr; 34(4):327-337. PubMed ID: 37574347
[TBL] [Abstract][Full Text] [Related]
2. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.
Liu X; Nie L; Zhang Y; Yan Y; Wang C; Colic M; Olszewski K; Horbath A; Chen X; Lei G; Mao C; Wu S; Zhuang L; Poyurovsky MV; James You M; Hart T; Billadeau DD; Chen J; Gan B
Nat Cell Biol; 2023 Mar; 25(3):404-414. PubMed ID: 36747082
[TBL] [Abstract][Full Text] [Related]
3. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.
Liu X; Zhang Y; Zhuang L; Olszewski K; Gan B
Genes Dis; 2021 Nov; 8(6):731-745. PubMed ID: 34522704
[TBL] [Abstract][Full Text] [Related]
4. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells.
Yan Y; Teng H; Hang Q; Kondiparthi L; Lei G; Horbath A; Liu X; Mao C; Wu S; Zhuang L; James You M; Poyurovsky MV; Ma L; Olszewski K; Gan B
Nat Commun; 2023 Jun; 14(1):3673. PubMed ID: 37339981
[TBL] [Abstract][Full Text] [Related]
5. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
Koppula P; Zhang Y; Zhuang L; Gan B
Cancer Commun (Lond); 2018 Apr; 38(1):12. PubMed ID: 29764521
[TBL] [Abstract][Full Text] [Related]
6. Disulfidptosis: Six Riddles Necessitating Solutions.
Wang X; Zheng C; Yao H; Guo Y; Wang Y; He G; Fu S; Deng X
Int J Biol Sci; 2024; 20(3):1042-1044. PubMed ID: 38322120
[TBL] [Abstract][Full Text] [Related]
7. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
Koppula P; Zhuang L; Gan B
Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
[TBL] [Abstract][Full Text] [Related]
8. In what area of biology has a "new" type of cell death been discovered?
Wang X; Lin J; Li Z; Wang M
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188955. PubMed ID: 37451411
[TBL] [Abstract][Full Text] [Related]
9. Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions.
Chen J; Ma B; Yang Y; Wang B; Hao J; Zhou X
Biomark Res; 2024 Apr; 12(1):45. PubMed ID: 38685115
[TBL] [Abstract][Full Text] [Related]
10. Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells.
Yamaguchi I; Katoh H
J Biochem; 2024 Mar; 175(3):313-322. PubMed ID: 38102738
[TBL] [Abstract][Full Text] [Related]
11. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer.
Jyotsana N; Ta KT; DelGiorno KE
Front Oncol; 2022; 12():858462. PubMed ID: 35280777
[TBL] [Abstract][Full Text] [Related]
12. Disulfidptosis, A Novel Cell Death Pathway: Molecular Landscape and Therapeutic Implications.
Gu Q; An Y; Xu M; Huang X; Chen X; Li X; Shan H; Zhang M
Aging Dis; 2024 May; ():. PubMed ID: 38739940
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma.
Qu J; Guan H; Zheng Q; Sun F
Int J Biol Macromol; 2024 Mar; 261(Pt 1):129584. PubMed ID: 38246443
[TBL] [Abstract][Full Text] [Related]
14. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M
J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11.
Wang C; Liu H; Xu S; Deng Y; Xu B; Yang T; Liu W
Cell Mol Neurobiol; 2023 Aug; 43(6):2627-2642. PubMed ID: 36988772
[TBL] [Abstract][Full Text] [Related]
16. NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors.
Zhong Z; Zhang C; Ni S; Ma M; Zhang X; Sang W; Lv T; Qian Z; Yi C; Yu B
Redox Biol; 2023 Jul; 63():102711. PubMed ID: 37148740
[TBL] [Abstract][Full Text] [Related]
17. A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options.
Criscuolo D; Morra F; Celetti A
Explor Target Antitumor Ther; 2022; 3(5):570-581. PubMed ID: 36338517
[TBL] [Abstract][Full Text] [Related]
18. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
[TBL] [Abstract][Full Text] [Related]
19. Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses.
Daher B; Parks SK; Durivault J; Cormerais Y; Baidarjad H; Tambutte E; Pouysségur J; Vučetić M
Cancer Res; 2019 Aug; 79(15):3877-3890. PubMed ID: 31175120
[TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene
Lin Y; Dong Y; Liu W; Fan X; Sun Y
Int J Gen Med; 2022; 15():2501-2513. PubMed ID: 35282646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
